573 related articles for article (PubMed ID: 38202898)
1. Biomarkers in Cancer Detection, Diagnosis, and Prognosis.
Das S; Dey MK; Devireddy R; Gartia MR
Sensors (Basel); 2023 Dec; 24(1):. PubMed ID: 38202898
[TBL] [Abstract][Full Text] [Related]
2. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
3. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
Shukla HD; Mahmood J; Vujaskovic Z
Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
[TBL] [Abstract][Full Text] [Related]
4. Novel secretome-to-transcriptome integrated or secreto-transcriptomic approach to reveal liquid biopsy biomarkers for predicting individualized prognosis of breast cancer patients.
Ankney JA; Xie L; Wrobel JA; Wang L; Chen X
BMC Med Genomics; 2019 May; 12(1):78. PubMed ID: 31146747
[TBL] [Abstract][Full Text] [Related]
5. The footprints of cancer development: Cancer biomarkers.
Ullah MF; Aatif M
Cancer Treat Rev; 2009 May; 35(3):193-200. PubMed ID: 19062197
[TBL] [Abstract][Full Text] [Related]
6. Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine.
Kamel HFM; Al-Amodi HSAB
Genomics Proteomics Bioinformatics; 2017 Aug; 15(4):220-235. PubMed ID: 28813639
[TBL] [Abstract][Full Text] [Related]
7. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
Mortensen MB
Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
[TBL] [Abstract][Full Text] [Related]
8. Microfluidics for Profiling miRNA Biomarker Panels in AI-Assisted Cancer Diagnosis and Prognosis.
Muthamilselvan S; Ramasami Sundhar Baabu P; Palaniappan A
Technol Cancer Res Treat; 2023; 22():15330338231185284. PubMed ID: 37365928
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of tumor immune biomarkers in biopsies from patients with refractory solid cancers.
Lambert T; Pobel C; Colmet-Daage L; Bigorgne A; RaubyY B; Aladro NS; Ter-MinassianN L; Kerisit M; Marabelle A; Besse B; Hollebecque A; Champiat S; Massard C; Morel D; Verlingue L; Scoazec JY
Cancer Treat Res Commun; 2022; 32():100611. PubMed ID: 35905672
[TBL] [Abstract][Full Text] [Related]
10. Non-coding RNAs as clinical biomarkers for cancer diagnosis and prognosis.
Mishra PJ
Expert Rev Mol Diagn; 2014 Nov; 14(8):917-9. PubMed ID: 25327490
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional profiling of circulating tumor cells: quantification and cancer progression (Review).
Wong IH
Oncol Rep; 2003; 10(1):229-35. PubMed ID: 12469174
[TBL] [Abstract][Full Text] [Related]
12. Predicting treatment Response based on Dual assessment of magnetic resonance Imaging kinetics and Circulating Tumor cells in patients with Head and Neck cancer (PREDICT-HN): matching 'liquid biopsy' and quantitative tumor modeling.
Ng SP; Bahig H; Wang J; Cardenas CE; Lucci A; Hall CS; Meas S; Sarli VN; Yuan Y; Urbauer DL; Ding Y; Ikner S; Dinh V; Elgohari BA; Johnson JM; Skinner HD; Gunn GB; Garden AS; Phan J; Rosenthal DI; Morrison WH; Frank SJ; Hutcheson KA; Mohamed ASR; Lai SY; Ferrarotto R; MacManus MP; Fuller CD
BMC Cancer; 2018 Sep; 18(1):903. PubMed ID: 30231854
[TBL] [Abstract][Full Text] [Related]
13. Liquid biopsy in breast cancer: A comprehensive review.
Alimirzaie S; Bagherzadeh M; Akbari MR
Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
[TBL] [Abstract][Full Text] [Related]
14. Genomic Markers in Prostate Cancer Decision Making.
Cucchiara V; Cooperberg MR; Dall'Era M; Lin DW; Montorsi F; Schalken JA; Evans CP
Eur Urol; 2018 Apr; 73(4):572-582. PubMed ID: 29129398
[TBL] [Abstract][Full Text] [Related]
15. Micro-RNAs as potential new molecular biomarkers in oncology: have they reached relevance for the clinical imaging sciences?
Berger F; Reiser MF
Theranostics; 2013 Nov; 3(12):943-52. PubMed ID: 24396505
[TBL] [Abstract][Full Text] [Related]
16. Liquid biopsy: Exosomal microRNAs as novel diagnostic and prognostic biomarkers in cancer.
Preethi KA; Selvakumar SC; Ross K; Jayaraman S; Tusubira D; Sekar D
Mol Cancer; 2022 Feb; 21(1):54. PubMed ID: 35172817
[TBL] [Abstract][Full Text] [Related]
17. Proteomics and personalized medicine: a focus on kidney disease.
Siwy J; Mischak H; Zürbig P
Expert Rev Proteomics; 2019 Sep; 16(9):773-782. PubMed ID: 31441341
[No Abstract] [Full Text] [Related]
18. Emerging noninvasive methylation biomarkers of cancer prognosis and drug response prediction.
Oliver J; Garcia-Aranda M; Chaves P; Alba E; Cobo-Dols M; Onieva JL; Barragan I
Semin Cancer Biol; 2022 Aug; 83():584-595. PubMed ID: 33757849
[TBL] [Abstract][Full Text] [Related]
19. Blood-based liquid biopsy: insights into early detection, prediction, and treatment monitoring of bladder cancer.
Li S; Xin K; Pan S; Wang Y; Zheng J; Li Z; Liu X; Liu B; Xu Z; Chen X
Cell Mol Biol Lett; 2023 Apr; 28(1):28. PubMed ID: 37016296
[TBL] [Abstract][Full Text] [Related]
20. Molecular Biomarkers in Cancer.
Sarhadi VK; Armengol G
Biomolecules; 2022 Jul; 12(8):. PubMed ID: 35892331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
